Anti-tTGIgA | IgEmA | Total | |||||
---|---|---|---|---|---|---|---|
group I | group II | group III | |||||
positive | negat. | positive | negat. | positive | negat. | % | |
positive | 85.7% | - | 85% | 1.7% | - | - | 52.1% |
borderline | - | 2.4% | 5% | - | 3% | - | 3.5% |
negative | 4.8% | 7.1% | 6.6% | 1.7% | - | 97% | 44.4% |
Anti-tTGIgA | IgEmA | Total | |||||
---|---|---|---|---|---|---|---|
group I | group II | group III | |||||
positive | negat. | positive | negat. | positive | negat. | % | |
positive | 85.7% | - | 85% | 1.7% | - | - | 52.1% |
borderline | - | 2.4% | 5% | - | 3% | - | 3.5% |
negative | 4.8% | 7.1% | 6.6% | 1.7% | - | 97% | 44.4% |